|
|
||||||||
J Thorac Cardiovasc Surg 1994;108:184-185
© 1994 Mosby, Inc.
LETTERS TO THE EDITOR |
Department of Anesthesia and Intensive Care Medicine
Department of Medical Chemistry and Biochemistry
University Innsbruck School of Medicine
Innsbruck, Austria
To the Editor:
Postbypass pulmonary dysfunction remains a relevant problem in patients undergoing heart operations with extracorporeal circulation
1 Experimental data suggest that activated leukocytes contribute to lung injury after cardiopulmonary bypass.
2 Leukocyte depletion by mechanical filtration istherefore recommended during cardiopulmonary bypass.
2 To determine the role of activated leukocytes in a clinical setting, we measured pulmonary function and plasma elastase concentrations as a marker of leukocyte activation
3 in patients undergoing aorta-coronary artery bypass operations.
Twenty-six patients undergoing elective, uncomplicated aorta-coronary bypass operations were investigated (age, 61.2 ± 7.0 years; mean ± standard deviation). In all patients, standard cardiopulmonary bypass techniques with moderate systemic hypothermia, aortic crossclamping, and cardioplegic arrest were used (bypass time, 117 ± 32.9 minutes; aortic crossclamp time, 59.4 ± 18.7 minutes; mean ± standard deviation). During aortic crossclamping, lungs were not ventilated and continuous positive airway pressure (8 mm Hg) was applied. Venous blood samples were drawn before anesthesia, before operation, before cardiopulmonary bypass (0 to 2, Fig. 1), with aortic unclamping, at 1, 2, 3, 4, 8, 12, 16, 20, and 24 hours later (3 to 12, Fig. 1), and daily thereafter for 7 days (13 to 19, Fig. 1). Elastase
1 proteinase inhibitor complex concentrations were measured with an immunoassay (PMN-Elastase IMAC; Merck, Darmstadt, Germany). Postbypass pulmonary function was assessed by the quotient of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) 1 and 3 hours after aortic unclamping.
4
|
Aorta-coronary bypass operations with cardiopulmonary bypass cause leukocyte activation, as shown by the marked increase in plasma elastase concentrations. Among various potential sources of pulmonary dysfunction after extracorporeal circulation, however, leukocyte activation seems to be a minor determinant of postbypass pulmonary function in this clinical setting.
References
This article has been cited by other articles:
![]() |
J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text] |
||||
![]() |
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text] |
||||
![]() |
P. Massoudy, S. Zahler, B. F. Becker, S. L. Braun, A. Barankay, and H. Meisner Evidence for Inflammatory Responses of the Lungs During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass Chest, January 1, 2001; 119(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Royston Systemic inflammatory responses to surgery with cardiopulmonary bypass Perfusion, May 1, 1996; 11(3): 177 - 189. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |